Clinical Trial 23322

• Overview

  Study Title:

  Survivorship in Patients with Multiple Myeloma Treated with Chimeric Antigen Receptor T-cell Therapy

  Objective:

  Aim 1: Identify psychosocial factors associated with clinical and patient-reported survivorship outcomes among RRMM patients treated with standard of care CAR T. Aim 2: Identify immune-related factors associated with clinical and patient-reported survivorship outcomes among RRMM patients treated with standard of care CAR T.

• Inclusion Criteria

  Key Inclusion Criteria:
  • ≥18 years old.
  • Has RRMM,
  • Scheduled to receive standard of care CAR T at Moffitt.
  • Able to speak and read English or Spanish.
  • Without documented or observable psychiatric or neurologic diagnoses that could interfere with participation (e.g., dementia, active psychosis).
  • Able to provide informed consent.

• Exclusion Criteria

  Key Exclusion Criteria:
  • Not meeting all of the inclusion criteria.

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.